Dermatology
Reports from N.N. Chen and Colleagues Advance Knowledge in Dermatology
Published in Cancer Weekly, February 7th, 2012
2012 FEB 7 -- According to the authors of recent research published in the journal Experimental Dermatology, "The effect of all-trans retinoic acid (ATRA) on cutaneous squamous cell carcinomas (c-SCC) has been poorly described. Because the imbalance of CRABP-II-mediated anticancer signalling and FABP5-mediated growth-promoting signalling was supposed to be related with ATRA sensitivities of cancer cells, COLO16 human c-SCC cell line was selected to check underlying mechanism leading to ATRA resistance by multiple experimental approaches."
"The results revealed that COLO 16 cells were resistant to 15 mu m ATRA treatment. FABP5 as well as the elements...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2012-02-07)
More Articles from Cancer Weekly
- Stem Cell Research
University of Padova Details Research in Stem Cell Research - Breast Cancer
Study Results from State University of New York Provide New Insights into Breast Cancer - Glioblastomas
Study Findings on Glioblastomas Are Outlined in Reports from Molecular Oncology Research Institute - Immunologic Receptors
Study Data from C. Li et al Provide New Insights into Immunologic Receptors - Erectile Dysfunction
Studies in the Area of Erectile Dysfunction Reported from Guy's & St. Thomas' NHS Foundation Trust - Oncology Research
Studies from University of Rochester Reveal New Findings on Oncology Research - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
